Granules recalls trazodone 50 mg tablets over foreign tablets or capsules found in bottles
The notice says some bottles of trazodone hydrochloride 50 mg tablets, 100 count, may contain foreign tablets or capsules, meaning pills that do not belong in the bottle.
What to do
The notice does not give instructions. Read the official notice for details.
Note from Recalled Today: Don't stop taking a prescribed medicine before you talk to your pharmacist or doctor.
Recall details
- Product
- Trazodone Hydrochloride, USP, 50 mg, 100-Count Bottle, Rx only, Manufactured by: Granules India Limited, Hyderabad, 500 081, India, Manufactured for: Granules Pharmaceuticals Inc., Chantilly, VA 20151, NDC 70010-231-01.
- Hazard
- Presence of Foreign Tablets/Capsules
- Units
- 71424 bottles.
- Where sold
- US Nationwide.
- FDA classification
- Class II · Ongoing
- Classified by FDA
- February 11, 2026
- Recall started
- January 26, 2026
- FDA enforcement report
- February 11, 2026
- Identifiers
- Codes: Batch # 6160008A, Exp Date: 12/31/2026
- FDA recall number: D-0305-2026
The headline, summary and steps above are written in plain English from the official notice below. Identifiers are copied exactly as the agency published them. Always check the official notice before you act.
Official notice
The notice's own wording from FDA.
- Product
- Trazodone Hydrochloride, USP, 50 mg, 100-Count Bottle, Rx only, Manufactured by: Granules India Limited, Hyderabad, 500 081, India, Manufactured for: Granules Pharmaceuticals Inc., Chantilly, VA 20151, NDC 70010-231-01.
- Reason for recall
- Presence of Foreign Tablets/Capsules
- Classification
- Class II (Ongoing)
- Distribution
- US Nationwide.
- Quantity
- 71424 bottles.
Related recalls
Teva recalls trazodone 50 mg tablets over foreign tablets or capsules found in bottles
The notice says some bottles of these trazodone tablets, a prescription medicine, contain foreign tablets or capsules, so a bottle may hold pills that are not trazodone.
Teva Pharmaceuticals USA, Inc · 175,392 bottles